Lumeneye Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 4, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Rectal Cancer
Interventions
DEVICE

International Cohort

"Assessing tumour response following neoadjuvant treatment in rectal cancer include :~* Digital rectal examination~* Rectal MRI~* Rectoscopy ( Lumeneye device)~The monitoring of tumour response intervals up to 6 months following completion of the neoadjuvant treatment at 8 weeks, at 16 weeks, at 24 weeks after the end of neoadjuvant treatment."

Trial Locations (8)

Unknown

RECRUITING

Clinique Tivoli-Ducos - Bordeaux Colorectal Institute, Bordeaux

RECRUITING

Hôpital Européen de Marseille, Marseille

RECRUITING

Hôpital Saint-Antoine - APHP, Paris

NOT_YET_RECRUITING

CHU de ROUEN, Rouen

RECRUITING

Humanitas Research Hospital, Milan

RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

University Hospital Vall D'Hebron, Barcelona

NOT_YET_RECRUITING

Imperial College London, London

All Listed Sponsors
lead

Bordeaux Colorectal Institute Academy

OTHER